CyMedica, a company based in Scottsdale, Arizona, won the European CE mark for its QB1 Muscle Activation System, a device designed to address quadriceps muscle atrophy that’s common after big knee surgeries.
The QB1 is a brace with a built-in neuromuscular electrical stimulator that uses high intensity signals to activate the muscle, but without producing the discomfort that would be expected from such an approach, according to the company.
The system relies on closed-loop monitoring to regularly adapt the intensity of the signal to the requirements and comfort of the patient. A wired remote helps set and adjust various parameters of the QB1.
“Securing the CE Mark for the QB1 System marks an important milestone for our company, greatly expanding our market opportunity to patients in Europe and paving the way for a global sales and distribution network. We are excited to have the clearance to deliver our revolutionary technology to millions of patients outside of the United States,” said Rob Morocco, President and CEO of CyMedica Orthopedics in a statement. “Having recently launched domestically, we will continue to dedicate ourselves to expanding our market penetration within the US as we evaluate the timing and structure of our plans to commercialize the QB1 internationally.”
Here’s a demo video on how to use the QB1: